Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 9 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0043226 | organelle | 2 | 2 |
GO:0043227 | membrane-bounded organelle | 3 | 2 |
GO:0043229 | intracellular organelle | 3 | 2 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 2 |
GO:0110165 | cellular anatomical entity | 1 | 3 |
GO:0016020 | membrane | 2 | 1 |
Related structures:
AlphaFold database: Q4QAG7
Term | Name | Level | Count |
---|---|---|---|
GO:0006139 | nucleobase-containing compound metabolic process | 3 | 2 |
GO:0006163 | purine nucleotide metabolic process | 5 | 2 |
GO:0006629 | lipid metabolic process | 3 | 12 |
GO:0006637 | acyl-CoA metabolic process | 4 | 2 |
GO:0006725 | cellular aromatic compound metabolic process | 3 | 2 |
GO:0006753 | nucleoside phosphate metabolic process | 4 | 2 |
GO:0006790 | sulfur compound metabolic process | 3 | 2 |
GO:0006793 | phosphorus metabolic process | 3 | 2 |
GO:0006796 | phosphate-containing compound metabolic process | 4 | 2 |
GO:0006807 | nitrogen compound metabolic process | 2 | 2 |
GO:0008152 | metabolic process | 1 | 12 |
GO:0009117 | nucleotide metabolic process | 5 | 2 |
GO:0009150 | purine ribonucleotide metabolic process | 6 | 2 |
GO:0009259 | ribonucleotide metabolic process | 5 | 2 |
GO:0009987 | cellular process | 1 | 2 |
GO:0019637 | organophosphate metabolic process | 3 | 2 |
GO:0019693 | ribose phosphate metabolic process | 4 | 2 |
GO:0033865 | nucleoside bisphosphate metabolic process | 5 | 2 |
GO:0033875 | ribonucleoside bisphosphate metabolic process | 6 | 2 |
GO:0034032 | purine nucleoside bisphosphate metabolic process | 5 | 2 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 2 |
GO:0035336 | long-chain fatty-acyl-CoA metabolic process | 6 | 2 |
GO:0035337 | fatty-acyl-CoA metabolic process | 5 | 2 |
GO:0035383 | thioester metabolic process | 3 | 2 |
GO:0043603 | amide metabolic process | 3 | 2 |
GO:0044237 | cellular metabolic process | 2 | 2 |
GO:0044238 | primary metabolic process | 2 | 12 |
GO:0044281 | small molecule metabolic process | 2 | 2 |
GO:0046483 | heterocycle metabolic process | 3 | 2 |
GO:0055086 | nucleobase-containing small molecule metabolic process | 3 | 2 |
GO:0071704 | organic substance metabolic process | 2 | 12 |
GO:0072521 | purine-containing compound metabolic process | 4 | 2 |
GO:1901135 | carbohydrate derivative metabolic process | 3 | 2 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 2 |
GO:1901564 | organonitrogen compound metabolic process | 3 | 2 |
GO:1901568 | fatty acid derivative metabolic process | 4 | 2 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 12 |
GO:0016491 | oxidoreductase activity | 2 | 12 |
GO:0016620 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor | 4 | 12 |
GO:0016903 | oxidoreductase activity, acting on the aldehyde or oxo group of donors | 3 | 12 |
GO:0080019 | alcohol-forming very long-chain fatty acyl-CoA reductase activity | 5 | 12 |
GO:0102965 | alcohol-forming long-chain fatty acyl-CoA reductase activity | 5 | 12 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 172 | 174 | PF00675 | 0.385 |
CLV_NRD_NRD_1 | 318 | 320 | PF00675 | 0.486 |
CLV_NRD_NRD_1 | 39 | 41 | PF00675 | 0.276 |
CLV_NRD_NRD_1 | 490 | 492 | PF00675 | 0.370 |
CLV_NRD_NRD_1 | 51 | 53 | PF00675 | 0.244 |
CLV_NRD_NRD_1 | 525 | 527 | PF00675 | 0.385 |
CLV_PCSK_FUR_1 | 426 | 430 | PF00082 | 0.483 |
CLV_PCSK_FUR_1 | 46 | 50 | PF00082 | 0.318 |
CLV_PCSK_KEX2_1 | 172 | 174 | PF00082 | 0.385 |
CLV_PCSK_KEX2_1 | 196 | 198 | PF00082 | 0.385 |
CLV_PCSK_KEX2_1 | 318 | 320 | PF00082 | 0.443 |
CLV_PCSK_KEX2_1 | 39 | 41 | PF00082 | 0.278 |
CLV_PCSK_KEX2_1 | 428 | 430 | PF00082 | 0.382 |
CLV_PCSK_KEX2_1 | 48 | 50 | PF00082 | 0.238 |
CLV_PCSK_KEX2_1 | 490 | 492 | PF00082 | 0.388 |
CLV_PCSK_KEX2_1 | 51 | 53 | PF00082 | 0.214 |
CLV_PCSK_PC1ET2_1 | 196 | 198 | PF00082 | 0.385 |
CLV_PCSK_PC1ET2_1 | 428 | 430 | PF00082 | 0.340 |
CLV_PCSK_PC1ET2_1 | 48 | 50 | PF00082 | 0.272 |
CLV_PCSK_SKI1_1 | 12 | 16 | PF00082 | 0.272 |
CLV_PCSK_SKI1_1 | 196 | 200 | PF00082 | 0.239 |
CLV_PCSK_SKI1_1 | 25 | 29 | PF00082 | 0.239 |
CLV_PCSK_SKI1_1 | 282 | 286 | PF00082 | 0.366 |
CLV_PCSK_SKI1_1 | 30 | 34 | PF00082 | 0.333 |
CLV_PCSK_SKI1_1 | 306 | 310 | PF00082 | 0.274 |
CLV_PCSK_SKI1_1 | 51 | 55 | PF00082 | 0.277 |
CLV_Separin_Metazoa | 74 | 78 | PF03568 | 0.385 |
DEG_APCC_DBOX_1 | 61 | 69 | PF00400 | 0.385 |
DEG_SPOP_SBC_1 | 369 | 373 | PF00917 | 0.552 |
DEG_SPOP_SBC_1 | 403 | 407 | PF00917 | 0.346 |
DOC_CYCLIN_RxL_1 | 303 | 311 | PF00134 | 0.269 |
DOC_MAPK_DCC_7 | 236 | 246 | PF00069 | 0.385 |
DOC_MAPK_gen_1 | 236 | 245 | PF00069 | 0.258 |
DOC_MAPK_gen_1 | 428 | 439 | PF00069 | 0.427 |
DOC_MAPK_HePTP_8 | 233 | 245 | PF00069 | 0.333 |
DOC_MAPK_MEF2A_6 | 236 | 245 | PF00069 | 0.301 |
DOC_MAPK_MEF2A_6 | 342 | 350 | PF00069 | 0.579 |
DOC_MAPK_MEF2A_6 | 432 | 441 | PF00069 | 0.449 |
DOC_MAPK_MEF2A_6 | 456 | 463 | PF00069 | 0.447 |
DOC_MAPK_RevD_3 | 160 | 173 | PF00069 | 0.385 |
DOC_PP2B_LxvP_1 | 469 | 472 | PF13499 | 0.419 |
DOC_PP4_FxxP_1 | 560 | 563 | PF00568 | 0.358 |
DOC_USP7_MATH_1 | 324 | 328 | PF00917 | 0.560 |
DOC_USP7_MATH_1 | 340 | 344 | PF00917 | 0.396 |
DOC_USP7_MATH_1 | 369 | 373 | PF00917 | 0.670 |
DOC_USP7_MATH_1 | 403 | 407 | PF00917 | 0.343 |
DOC_USP7_MATH_1 | 462 | 466 | PF00917 | 0.366 |
DOC_USP7_UBL2_3 | 306 | 310 | PF12436 | 0.261 |
DOC_USP7_UBL2_3 | 428 | 432 | PF12436 | 0.406 |
DOC_WW_Pin1_4 | 329 | 334 | PF00397 | 0.629 |
DOC_WW_Pin1_4 | 376 | 381 | PF00397 | 0.564 |
DOC_WW_Pin1_4 | 472 | 477 | PF00397 | 0.496 |
DOC_WW_Pin1_4 | 67 | 72 | PF00397 | 0.314 |
LIG_14-3-3_CanoR_1 | 111 | 115 | PF00244 | 0.294 |
LIG_14-3-3_CanoR_1 | 342 | 350 | PF00244 | 0.535 |
LIG_14-3-3_CanoR_1 | 411 | 415 | PF00244 | 0.473 |
LIG_14-3-3_CanoR_1 | 526 | 532 | PF00244 | 0.336 |
LIG_14-3-3_CterR_2 | 575 | 579 | PF00244 | 0.438 |
LIG_AP2alpha_2 | 257 | 259 | PF02296 | 0.385 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.365 |
LIG_BRCT_BRCA1_1 | 69 | 73 | PF00533 | 0.245 |
LIG_CaM_IQ_9 | 308 | 323 | PF13499 | 0.386 |
LIG_CaM_NSCaTE_8 | 262 | 269 | PF13499 | 0.239 |
LIG_deltaCOP1_diTrp_1 | 506 | 511 | PF00928 | 0.233 |
LIG_EH1_1 | 298 | 306 | PF00400 | 0.251 |
LIG_FHA_1 | 164 | 170 | PF00498 | 0.264 |
LIG_FHA_1 | 18 | 24 | PF00498 | 0.270 |
LIG_FHA_1 | 220 | 226 | PF00498 | 0.302 |
LIG_FHA_1 | 273 | 279 | PF00498 | 0.303 |
LIG_FHA_1 | 369 | 375 | PF00498 | 0.690 |
LIG_FHA_1 | 380 | 386 | PF00498 | 0.665 |
LIG_FHA_2 | 389 | 395 | PF00498 | 0.565 |
LIG_FHA_2 | 501 | 507 | PF00498 | 0.273 |
LIG_GBD_Chelix_1 | 300 | 308 | PF00786 | 0.254 |
LIG_LIR_Apic_2 | 254 | 258 | PF02991 | 0.273 |
LIG_LIR_Apic_2 | 557 | 563 | PF02991 | 0.359 |
LIG_LIR_Gen_1 | 496 | 504 | PF02991 | 0.367 |
LIG_LIR_Gen_1 | 506 | 517 | PF02991 | 0.285 |
LIG_LIR_Gen_1 | 540 | 549 | PF02991 | 0.317 |
LIG_LIR_Gen_1 | 82 | 92 | PF02991 | 0.363 |
LIG_LIR_Nem_3 | 165 | 171 | PF02991 | 0.303 |
LIG_LIR_Nem_3 | 34 | 38 | PF02991 | 0.308 |
LIG_LIR_Nem_3 | 413 | 417 | PF02991 | 0.351 |
LIG_LIR_Nem_3 | 496 | 502 | PF02991 | 0.367 |
LIG_LIR_Nem_3 | 506 | 512 | PF02991 | 0.284 |
LIG_LIR_Nem_3 | 528 | 534 | PF02991 | 0.359 |
LIG_LIR_Nem_3 | 535 | 541 | PF02991 | 0.303 |
LIG_LIR_Nem_3 | 70 | 76 | PF02991 | 0.246 |
LIG_LIR_Nem_3 | 82 | 88 | PF02991 | 0.239 |
LIG_MYND_1 | 563 | 567 | PF01753 | 0.405 |
LIG_PCNA_yPIPBox_3 | 302 | 316 | PF02747 | 0.330 |
LIG_PDZ_Class_1 | 574 | 579 | PF00595 | 0.450 |
LIG_Pex14_1 | 507 | 511 | PF04695 | 0.260 |
LIG_SH2_CRK | 29 | 33 | PF00017 | 0.385 |
LIG_SH2_CRK | 509 | 513 | PF00017 | 0.309 |
LIG_SH2_CRK | 541 | 545 | PF00017 | 0.308 |
LIG_SH2_GRB2like | 168 | 171 | PF00017 | 0.287 |
LIG_SH2_GRB2like | 56 | 59 | PF00017 | 0.333 |
LIG_SH2_NCK_1 | 541 | 545 | PF00017 | 0.275 |
LIG_SH2_PTP2 | 460 | 463 | PF00017 | 0.365 |
LIG_SH2_SRC | 545 | 548 | PF00017 | 0.305 |
LIG_SH2_SRC | 56 | 59 | PF00017 | 0.333 |
LIG_SH2_STAP1 | 534 | 538 | PF00017 | 0.283 |
LIG_SH2_STAP1 | 541 | 545 | PF00017 | 0.221 |
LIG_SH2_STAT5 | 168 | 171 | PF00017 | 0.239 |
LIG_SH2_STAT5 | 223 | 226 | PF00017 | 0.239 |
LIG_SH2_STAT5 | 255 | 258 | PF00017 | 0.238 |
LIG_SH2_STAT5 | 299 | 302 | PF00017 | 0.443 |
LIG_SH2_STAT5 | 42 | 45 | PF00017 | 0.250 |
LIG_SH2_STAT5 | 453 | 456 | PF00017 | 0.431 |
LIG_SH2_STAT5 | 460 | 463 | PF00017 | 0.386 |
LIG_SH2_STAT5 | 539 | 542 | PF00017 | 0.304 |
LIG_SH2_STAT5 | 56 | 59 | PF00017 | 0.158 |
LIG_SH3_3 | 374 | 380 | PF00018 | 0.709 |
LIG_SH3_3 | 560 | 566 | PF00018 | 0.351 |
LIG_SUMO_SIM_anti_2 | 370 | 379 | PF11976 | 0.555 |
LIG_SUMO_SIM_anti_2 | 64 | 70 | PF11976 | 0.304 |
LIG_SUMO_SIM_par_1 | 346 | 351 | PF11976 | 0.552 |
LIG_SUMO_SIM_par_1 | 370 | 379 | PF11976 | 0.555 |
LIG_TYR_ITAM | 444 | 463 | PF00017 | 0.307 |
LIG_TYR_ITIM | 27 | 32 | PF00017 | 0.361 |
LIG_TYR_ITIM | 450 | 455 | PF00017 | 0.382 |
LIG_UBA3_1 | 27 | 33 | PF00899 | 0.240 |
LIG_UBA3_1 | 304 | 310 | PF00899 | 0.254 |
MOD_CDC14_SPxK_1 | 475 | 478 | PF00782 | 0.503 |
MOD_CDK_SPK_2 | 472 | 477 | PF00069 | 0.488 |
MOD_CDK_SPxK_1 | 472 | 478 | PF00069 | 0.496 |
MOD_CK1_1 | 10 | 16 | PF00069 | 0.357 |
MOD_CK1_1 | 379 | 385 | PF00069 | 0.623 |
MOD_CK1_1 | 388 | 394 | PF00069 | 0.669 |
MOD_CK1_1 | 525 | 531 | PF00069 | 0.417 |
MOD_CK2_1 | 403 | 409 | PF00069 | 0.533 |
MOD_CK2_1 | 500 | 506 | PF00069 | 0.273 |
MOD_CK2_1 | 565 | 571 | PF00069 | 0.476 |
MOD_Cter_Amidation | 426 | 429 | PF01082 | 0.410 |
MOD_Cter_Amidation | 46 | 49 | PF01082 | 0.333 |
MOD_GlcNHglycan | 209 | 212 | PF01048 | 0.369 |
MOD_GlcNHglycan | 326 | 329 | PF01048 | 0.629 |
MOD_GlcNHglycan | 343 | 346 | PF01048 | 0.642 |
MOD_GlcNHglycan | 364 | 367 | PF01048 | 0.726 |
MOD_GlcNHglycan | 387 | 390 | PF01048 | 0.715 |
MOD_GlcNHglycan | 567 | 570 | PF01048 | 0.552 |
MOD_GSK3_1 | 10 | 17 | PF00069 | 0.320 |
MOD_GSK3_1 | 219 | 226 | PF00069 | 0.239 |
MOD_GSK3_1 | 433 | 440 | PF00069 | 0.527 |
MOD_LATS_1 | 430 | 436 | PF00433 | 0.424 |
MOD_N-GLC_1 | 10 | 15 | PF02516 | 0.434 |
MOD_N-GLC_1 | 512 | 517 | PF02516 | 0.260 |
MOD_NEK2_1 | 124 | 129 | PF00069 | 0.273 |
MOD_NEK2_1 | 151 | 156 | PF00069 | 0.356 |
MOD_NEK2_1 | 272 | 277 | PF00069 | 0.269 |
MOD_NEK2_1 | 308 | 313 | PF00069 | 0.286 |
MOD_NEK2_1 | 385 | 390 | PF00069 | 0.739 |
MOD_NEK2_1 | 437 | 442 | PF00069 | 0.490 |
MOD_NEK2_1 | 500 | 505 | PF00069 | 0.355 |
MOD_NEK2_2 | 433 | 438 | PF00069 | 0.385 |
MOD_PIKK_1 | 308 | 314 | PF00454 | 0.309 |
MOD_PKA_2 | 110 | 116 | PF00069 | 0.313 |
MOD_PKA_2 | 246 | 252 | PF00069 | 0.248 |
MOD_PKA_2 | 341 | 347 | PF00069 | 0.714 |
MOD_PKA_2 | 410 | 416 | PF00069 | 0.488 |
MOD_PKA_2 | 525 | 531 | PF00069 | 0.452 |
MOD_PKA_2 | 554 | 560 | PF00069 | 0.407 |
MOD_Plk_1 | 10 | 16 | PF00069 | 0.430 |
MOD_Plk_1 | 369 | 375 | PF00069 | 0.552 |
MOD_Plk_1 | 500 | 506 | PF00069 | 0.406 |
MOD_Plk_1 | 512 | 518 | PF00069 | 0.385 |
MOD_Plk_1 | 97 | 103 | PF00069 | 0.391 |
MOD_Plk_2-3 | 493 | 499 | PF00069 | 0.304 |
MOD_Plk_4 | 246 | 252 | PF00069 | 0.246 |
MOD_Plk_4 | 417 | 423 | PF00069 | 0.516 |
MOD_ProDKin_1 | 329 | 335 | PF00069 | 0.633 |
MOD_ProDKin_1 | 376 | 382 | PF00069 | 0.565 |
MOD_ProDKin_1 | 472 | 478 | PF00069 | 0.496 |
MOD_ProDKin_1 | 67 | 73 | PF00069 | 0.314 |
MOD_SUMO_rev_2 | 349 | 354 | PF00179 | 0.522 |
TRG_DiLeu_BaEn_1 | 209 | 214 | PF01217 | 0.310 |
TRG_DiLeu_BaEn_2 | 394 | 400 | PF01217 | 0.531 |
TRG_ENDOCYTIC_2 | 29 | 32 | PF00928 | 0.293 |
TRG_ENDOCYTIC_2 | 42 | 45 | PF00928 | 0.179 |
TRG_ENDOCYTIC_2 | 447 | 450 | PF00928 | 0.416 |
TRG_ENDOCYTIC_2 | 452 | 455 | PF00928 | 0.401 |
TRG_ENDOCYTIC_2 | 460 | 463 | PF00928 | 0.359 |
TRG_ENDOCYTIC_2 | 509 | 512 | PF00928 | 0.306 |
TRG_ENDOCYTIC_2 | 541 | 544 | PF00928 | 0.308 |
TRG_ENDOCYTIC_2 | 547 | 550 | PF00928 | 0.287 |
TRG_ER_diArg_1 | 171 | 173 | PF00400 | 0.385 |
TRG_ER_diArg_1 | 318 | 321 | PF00400 | 0.462 |
TRG_ER_diArg_1 | 38 | 40 | PF00400 | 0.317 |
TRG_ER_diArg_1 | 448 | 451 | PF00400 | 0.437 |
TRG_ER_diArg_1 | 489 | 491 | PF00400 | 0.335 |
TRG_ER_diArg_1 | 49 | 52 | PF00400 | 0.271 |
TRG_NES_CRM1_1 | 493 | 506 | PF08389 | 0.335 |
TRG_NLS_MonoExtC_3 | 47 | 52 | PF00514 | 0.303 |
TRG_NLS_MonoExtN_4 | 172 | 177 | PF00514 | 0.304 |
TRG_NLS_MonoExtN_4 | 46 | 52 | PF00514 | 0.301 |
TRG_Pf-PMV_PEXEL_1 | 176 | 181 | PF00026 | 0.238 |
TRG_Pf-PMV_PEXEL_1 | 30 | 34 | PF00026 | 0.317 |
TRG_Pf-PMV_PEXEL_1 | 464 | 468 | PF00026 | 0.460 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1I721 | Leptomonas seymouri | 71% | 100% |
A0A0S4ILT5 | Bodo saltans | 43% | 100% |
A0A1X0NVR7 | Trypanosomatidae | 49% | 100% |
A0A3Q8ICX8 | Leishmania donovani | 95% | 100% |
A0A422N8G4 | Trypanosoma rangeli | 47% | 98% |
A4HDM4 | Leishmania braziliensis | 86% | 100% |
C9ZWE8 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 49% | 93% |
E9AH71 | Leishmania infantum | 95% | 100% |
E9AX09 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 93% | 100% |
Q9LXN3 | Arabidopsis thaliana | 27% | 100% |
V5AVK6 | Trypanosoma cruzi | 49% | 98% |